Swiss perspectives in 10 languages

Swiss hospitals launch drug trial to prevent Covid-19 infection

test
The trial is enrolling 400 people who will be divided into three groups. Keystone / Salvatore Di Nolfi

Researchers in Geneva and Basel have launched a clinical trial to test two drugs in the prevention of infection among people who were in contact with newly confirmed Covid-19 patients.

The trialExternal link announced on Thursday is intended to help monitor and contain any new Covid-19 outbreaks at a time when many countries, including Switzerland, are easing restrictions.

Treating these exposed people preventively is called “post-exposure ring chemoprophylaxis” and is considered a pragmatic way to slow or contain the spread of a virus at the early stages.

“Protecting contact persons from getting sick is not only desirable from an individual’s point of view but could also prove an innovative public health approach,” said Alexandra Calmy, who leads the project at the University Hospitals Geneva.

The trial, now in Phase 3, is enrolling 400 people who were in close contact with newly diagnosed COVID-19 patients. They will be randomly divided into three groups.

External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Weekly top stories

Keep up to date with the best stories from SWI swissinfo.ch on a range of topics, straight into your mailbox.

Weekly

The SBC Privacy Policy provides additional information on how your data is processed.

One of the two drugs that will be assessed is the antimalarial drug hydroxychloroquine, which has been hotly debated by politicians and public health experts as a possible treatment to Covid-19.

Novartis’ Sandoz division is one of the largest makers of the drug and has donated doses to Swiss hospitals as part of its Covid-19 response.

Participants in the second group will receive the anti-HIV drug lopinavir/ritonavir. The third group will not receive any drugs. Three weeks after enrolment, participants will be checked to see if they develop infection.

“If one or both of the two repurposed drugs should prove efficacious, this would allow us to react rapidly when new cases emerge thereby helping us to flatten the feared second and third waves of the pandemic,” said Niklaus Labhardt, who is a Senior Physician at the University Hospital Basel.

The trial is being run by Geneva University Hospitals, Basel University Hospital and the Swiss Tropical and Public Health Institute.

There are more than 60 approved research or clinical trials on Covid-19 underway in Switzerland. This is one of five Phase 3 trialsExternal link being run at Swiss hospitals according to the Swiss Association of Research Ethics Committees.

More


Popular Stories

Most Discussed

News

Swiss adults above average in basic skills

More

Swiss adults above average in basic skills

This content was published on In an international comparison, Swiss adults perform above average in the basic skills of reading, everyday math and problem solving.

Read more: Swiss adults above average in basic skills
Parliament clears the bill for a new start with E-ID

More

Swiss parliament clears way for new start with e-ID

This content was published on A new attempt to introduce electronic proof of identity has been made in Switzerland. The Senate has resolved the final differences in the legal provisions on a state e-ID.

Read more: Swiss parliament clears way for new start with e-ID
Rare Roman coin sold for 1.89 million francs at auction

More

Rare Roman coin auctioned for almost CHF2 million in Geneva

This content was published on A rare Roman coin with a portrait of Brutus, the assassin of Julius Caesar, was sold at a Geneva auction on Monday for CHF1.89 million ($2.15 million), according to the organiser of the sale.

Read more: Rare Roman coin auctioned for almost CHF2 million in Geneva
Council of States says yes to the federal budget without a dissenting vote

More

Swiss Senate approves federal budget without opposition

This content was published on The Swiss army will receive an additional CHF530 million in 2025, and no cuts will be made to direct payments for agriculture. What is unclear is how much will be saved on foreign aid.

Read more: Swiss Senate approves federal budget without opposition
SEM suspends asylum procedure for asylum seekers from Syria

More

Swiss suspend decisions on asylum-seekers from Syria

This content was published on Asylum procedures and decisions for asylum-seekers from Syria will be suspended with immediate effect until the situation can be reassessed, the State Secretariat for Migration (SEM) said.

Read more: Swiss suspend decisions on asylum-seekers from Syria

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR